314 related articles for article (PubMed ID: 32540226)
1. Associations Between End-of-Life Expenditures and Hospice Stay Length Vary by Clinical Condition and Expenditure Duration.
Hung P; Hsu SH; Wang SY
Value Health; 2020 Jun; 23(6):697-704. PubMed ID: 32540226
[TBL] [Abstract][Full Text] [Related]
2. Longer Periods Of Hospice Service Associated With Lower End-Of-Life Spending In Regions With High Expenditures.
Wang S; Hsu SH; Huang S; Soulos PR; Gross CP
Health Aff (Millwood); 2017 Feb; 36(2):328-336. PubMed ID: 28167723
[TBL] [Abstract][Full Text] [Related]
3. Government expenditures at the end of life for short- and long-stay nursing home residents: differences by hospice enrollment status.
Miller SC; Intrator O; Gozalo P; Roy J; Barber J; Mor V
J Am Geriatr Soc; 2004 Aug; 52(8):1284-92. PubMed ID: 15271115
[TBL] [Abstract][Full Text] [Related]
4. Impact of hospice disenrollment on health care use and medicare expenditures for patients with cancer.
Carlson MD; Herrin J; Du Q; Epstein AJ; Barry CL; Morrison RS; Back AL; Bradley EH
J Clin Oncol; 2010 Oct; 28(28):4371-5. PubMed ID: 20805463
[TBL] [Abstract][Full Text] [Related]
5. Hospice Use, Hospitalization, and Medicare Spending at the End of Life.
Zuckerman RB; Stearns SC; Sheingold SH
J Gerontol B Psychol Sci Soc Sci; 2016 May; 71(3):569-80. PubMed ID: 26655645
[TBL] [Abstract][Full Text] [Related]
6. What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program?
Taylor DH; Ostermann J; Van Houtven CH; Tulsky JA; Steinhauser K
Soc Sci Med; 2007 Oct; 65(7):1466-78. PubMed ID: 17600605
[TBL] [Abstract][Full Text] [Related]
7. Hospice care, cancer-directed therapy, and Medicare expenditures among older patients dying with malignant brain tumors.
Dover LL; Dulaney CR; Williams CP; Fiveash JB; Jackson BE; Warren PP; Kvale EA; Boggs DH; Rocque GB
Neuro Oncol; 2018 Jun; 20(7):986-993. PubMed ID: 29156054
[TBL] [Abstract][Full Text] [Related]
8. Hospice Visit Patterns in the Last Seven Days of Life and the Service Intensity Add-On Payment.
Gozalo PL; Teno JM; Spence C
J Palliat Med; 2017 Dec; 20(12):1378-1384. PubMed ID: 28622481
[TBL] [Abstract][Full Text] [Related]
9. Medicare program expenditures associated with hospice use.
Campbell DE; Lynn J; Louis TA; Shugarman LR
Ann Intern Med; 2004 Feb; 140(4):269-77. PubMed ID: 14970150
[TBL] [Abstract][Full Text] [Related]
10. Health System and Beneficiary Costs Associated With Intensive End-of-Life Medical Services.
Gidwani-Marszowski R; Asch SM; Mor V; Wagner TH; Faricy-Anderson K; Illarmo S; Hsin G; Patel MI; Ramchandran K; Lorenz KA; Needleman J
JAMA Netw Open; 2019 Sep; 2(9):e1912161. PubMed ID: 31560384
[TBL] [Abstract][Full Text] [Related]
11. Hospice care and resource utilization in Medicare beneficiaries with heart failure.
Blecker S; Anderson GF; Herbert R; Wang NY; Brancati FL
Med Care; 2011 Nov; 49(11):985-91. PubMed ID: 22002645
[TBL] [Abstract][Full Text] [Related]
12. Associations Between End-of-Life Cancer Care Patterns and Medicare Expenditures.
Wang SY; Hall J; Pollack CE; Adelson K; Davidoff AJ; Long JB; Gross CP
J Natl Compr Canc Netw; 2016 Aug; 14(8):1001-8. PubMed ID: 27496116
[TBL] [Abstract][Full Text] [Related]
13. Age and gender differences in medicare expenditures and service utilization at the end of life for lung cancer decedents.
Shugarman LR; Bird CE; Schuster CR; Lynn J
Womens Health Issues; 2008; 18(3):199-209. PubMed ID: 18457755
[TBL] [Abstract][Full Text] [Related]
14. Regional variation in the association between advance directives and end-of-life Medicare expenditures.
Nicholas LH; Langa KM; Iwashyna TJ; Weir DR
JAMA; 2011 Oct; 306(13):1447-53. PubMed ID: 21972306
[TBL] [Abstract][Full Text] [Related]
15. Will Changes to Medicare Payment Rates Alter Hospice's Cost-Saving Ability?
Taylor DH; Bhavsar NA; Bull JH; Kassner CT; Olson A; Boucher NA
J Palliat Med; 2018 May; 21(5):645-651. PubMed ID: 29412764
[TBL] [Abstract][Full Text] [Related]
16. Changes in Medicare costs with the growth of hospice care in nursing homes.
Gozalo P; Plotzke M; Mor V; Miller SC; Teno JM
N Engl J Med; 2015 May; 372(19):1823-31. PubMed ID: 25946281
[TBL] [Abstract][Full Text] [Related]
17. Managed care, hospice use, site of death, and medical expenditures in the last year of life.
Emanuel EJ; Ash A; Yu W; Gazelle G; Levinsky NG; Saynina O; McClellan M; Moskowitz M
Arch Intern Med; 2002 Aug 12-26; 162(15):1722-8. PubMed ID: 12153375
[TBL] [Abstract][Full Text] [Related]
18. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents.
Shugarman LR; Bird CE; Schuster CR; Lynn J
J Womens Health (Larchmt); 2007 Mar; 16(2):214-27. PubMed ID: 17388738
[TBL] [Abstract][Full Text] [Related]
19. Hospice effect on government expenditures among nursing home residents.
Gozalo PL; Miller SC; Intrator O; Barber JP; Mor V
Health Serv Res; 2008 Feb; 43(1 Pt 1):134-53. PubMed ID: 18211522
[TBL] [Abstract][Full Text] [Related]
20. Escalating Health Care Expenditures in Cancer Decedents' Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan.
Hung YN; Liu TW; Wen FH; Chou WC; Tang ST
Oncologist; 2017 Apr; 22(4):460-469. PubMed ID: 28232596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
